Approval sought for Femara in early post-surgery use Approval has been sought in the U.

Approval sought for Femara in early post-surgery use Approval has been sought in the U.S. And European countries, by Swiss drug maker Novartis, for its breast-cancer drug Femara to be utilized after surgery to help older females fight tumours immediately read more . The acceptance, if granted, means that the medication could be available for far more women. Femara already has approval for use in post-menopausal women who’ve completed a 5-yr span of the post-surgery treatment tamoxifen, which is the current standard treatment, and also for women whose breasts cancer has spread to other areas of the physical body. Related StoriesSausages With Antioxidants From Berries To Prevent CancerViralytics enters into scientific trial collaboration agreement with MSDNew results reveal association between colorectal malignancy and melanoma medication treatmentFemara may be the second drug, in a new class of hormone-based breast-cancer treatments, called aromatase inhibitors, to have obviously demonstrated an edge over tamoxifen in trials.


ArQule announces SPA with FDA for ARQ 197 Phase 3 trial design for NSCLC ArQule, Inc. today announced a Special Protocol Assessment contract with the U.S. Food and Drug Administration for the design of a Phase 3 trial of ARQ 197 in individuals with non-small cell lung cancers of non-squamous histology. Daiichi Sankyo Co., Ltd., the holder of the Investigational New Medication application for ARQ 197 and ArQule’s partner for the development of the compound, will conduct the Stage 3 trial, which is planned for initiation this year later. Related StoriesNew RNA test of blood platelets can be used to identify area of cancerFDA grants accelerated acceptance for Tagrisso to treat patients with advanced NSCLCMeat-rich diet may increase kidney cancer riskThe trial will be a randomized, double-blinded study of erlotinib plus ARQ 197 in individuals with advanced or metatstatic NSCLC of non-squamous histology locally.

Other entries from category "nutrition":

Random entries